tiprankstipranks
Janux Therapeutics Inc (JANX)
NASDAQ:JANX
US Market
Holding JANX?
Track your performance easily

Janux Therapeutics Inc (JANX) Financial Statements

301 Followers

Janux Therapeutics Inc Financial Overview

Janux Therapeutics Inc's market cap is currently ―. The company's EPS TTM is $-1.175; its P/E ratio is -48.33; Janux Therapeutics Inc is scheduled to report earnings on March 7, 2025, and the estimated EPS forecast is $-0.43. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 439.00K$ 8.90M$ 1.25M$ 2.46M$ 2.52M
Gross Profit$ 439.00K$ 8.90M$ 1.25M$ 2.46M$ 2.52M
EBIT$ -28.06M$ -5.96M$ -20.16M$ -16.14M$ -15.81M
EBITDA$ -27.55M$ -3.67M$ -19.63M$ -15.61M$ -15.31M
Net Income Common Stockholders$ -28.06M$ -5.96M$ -14.76M$ -11.76M$ -11.57M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 658.03M$ 646.29M$ 651.76M$ 344.03M$ 349.71M
Total Assets$ 695.02M$ 691.41M$ 688.98M$ 380.41M$ 386.85M
Total Debt$ 23.43M$ 23.82M$ 24.18M$ 24.54M$ 24.89M
Net Debt$ -634.60M$ -622.47M$ -627.58M$ -319.49M$ -324.82M
Total Liabilities$ 38.91M$ 33.73M$ 33.22M$ 36.06M$ 37.90M
Stockholders Equity$ 656.10M$ 657.66M$ 655.76M$ 344.35M$ 348.95M
Cash Flow-
Free Cash Flow$ -2.26M$ -10.12M$ -15.03M$ -10.42M$ -12.18M
Operating Cash Flow$ -2.23M$ -10.02M$ -14.84M$ -9.90M$ -11.71M
Investing Cash Flow$ 12.67M$ -190.88M$ -113.74M$ 11.12M$ -61.45M
Financing Cash Flow$ 1.65M$ 2.77M$ 322.17M$ 831.00K$ 56.61M
Currency in USD

Janux Therapeutics Inc Earnings and Revenue History

Janux Therapeutics Inc Debt to Assets

Janux Therapeutics Inc Cash Flow

Janux Therapeutics Inc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis